Publication | Open Access
OA05.07 IMpower132: PFS and Safety Results with 1L Atezolizumab + Carboplatin/Cisplatin + Pemetrexed in Stage IV Non-Squamous NSCLC
120
Citations
0
References
2018
Year
OncologyMedicinePharmacotherapyOa05.07 Impower132Safety ResultsCancer TreatmentAnti-cancer AgentPharmacologyRadiation Oncology
No additional data available for this publication yet. Check back later!